Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Treatment With CsA-PG Ophthalmic Gel in Dry Eye Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the efficacy and safety of CsA-PG Ophthalmic Gel for Dry Eye Disease. The study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• CsA-PG Ophthalmic Gel (cyclosporine ophthalmic gel)

Snippet

Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | Conditions: Dry Eye Disease | Phase 3 | Status: NOT_YET_RECRUITING